HUTCHMED (China) Ltd Files Routine 6-K Report

Ticker: HMDCF · Form: 6-K · Filed: Jun 17, 2024 · CIK: 1648257

Sentiment: neutral

Topics: regulatory-filing, 6-K, foreign-private-issuer

TL;DR

HUTCHMED filed a 6-K, just a routine update, nothing major to see here.

AI Summary

HUTCHMED (China) Limited filed a Form 6-K on June 17, 2024, reporting information as of that date. The filing is a routine report for a foreign private issuer and does not contain specific financial updates or material events beyond its status as a periodic filing.

Why It Matters

This filing indicates HUTCHMED is meeting its regulatory reporting obligations as a foreign private issuer, which is standard practice for companies listed on US exchanges.

Risk Assessment

Risk Level: low — This is a standard periodic filing by a foreign private issuer and does not contain new material information or financial disclosures.

Key Players & Entities

FAQ

What type of filing is this?

This is a Form 6-K, a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

Who is the filer of this report?

The filer is HUTCHMED (China) Limited.

What is the filing date?

The filing date is June 17, 2024.

What is the company's Standard Industrial Classification?

The company's Standard Industrial Classification is 2834, which corresponds to Pharmaceutical Preparations.

Does HUTCHMED file an annual report on Form 20-F or 40-F?

HUTCHMED files its annual reports under cover of Form 20-F.

Filing Stats: 168 words · 1 min read · ~1 pages · Grade level 13.3 · Accepted 2024-06-17 06:03:33

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of June 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to HUTCHMED highlights publication of Phase III ESLIM-01 results in The Lancet Haematology 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: June 17, 2024 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing